Benign prostatic hyperplasia

被引：4
|
作者：
Parnham, Arie [1 ]
Haq, Ahsanul [1 ]
机构：
[1] Royal Preston Hosptial, Dept Urol, Sharoe Green Lane, Preston PR2 9HT, Lancs, England
来源：
JOURNAL OF CLINICAL UROLOGY | 2013年 / 6卷 / 01期
关键词：
alpha-blockers; NICE; benign prostatic hyperplasia; combination therapy; EAU; lower urinary tract symptoms; post-void residual; PSA; symptoms scores; TURP; 5-infinity-reductase inhibitors;
D O I：
10.1177/2051415812473243
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Male Lower Urinary Tract symptoms (LUTs) and Benign Prostatic Hyperplasia (BPH) provide a significant proportion of the core urologists workload, and will continue to do so for the foreseeable future with an increasingly elderly population. This review sets out to provide an overview of the current understanding around BPH and male LUTs as well as investigations and treatment options.
引用
收藏
页码：24 / 31
页数：8
相关论文
共 50 条
  • [1] Benign prostatic hyperplasia
    Hernandez, Sarelis Infante
    Rivas, Juan Gomez
    Sierra, Jesus Moreno
    MEDICINA CLINICA, 2024, 163 (08): : 407 - 414
  • [2] α-Blockers for benign prostatic hyperplasia: the new era
    Lepor, Herbert
    Kazzazi, Amir
    Djavan, Bob
    CURRENT OPINION IN UROLOGY, 2012, 22 (01) : 7 - 15
  • [3] Benign prostatic hyperplasia
    Shabbir, M
    Mumtaz, FH
    JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2004, 124 (05): : 222 - 227
  • [4] Benign Prostatic Hyperplasia
    Paolone, David R.
    CLINICS IN GERIATRIC MEDICINE, 2010, 26 (02) : 223 - +
  • [5] Benign Prostatic Hyperplasia
    Langan, Robert C.
    PRIMARY CARE, 2019, 46 (02): : 223 - +
  • [6] Treatment options for benign prostatic hyperplasia in older men
    Miano, Roberto
    De Nunzio, Cosimo
    Asimakopoulos, Anastasios D.
    Germani, Stefano
    Tubaro, Andrea
    MEDICAL SCIENCE MONITOR, 2008, 14 (07): : RA94 - RA102
  • [7] Pharmacological treatment of benign prostatic hyperplasia
    Oelke, M.
    Martinelli, E.
    UROLOGE, 2016, 55 (01): : 81 - 94
  • [8] Pharmacological treatment of benign prostatic hyperplasia
    Oelke, M.
    Kuczyk, M. A.
    Herrmann, T. R. W.
    UROLOGE, 2009, 48 (11): : 1365 - 1375
  • [9] Hormonal manipulation of benign prostatic hyperplasia
    Rick, Ferenc G.
    Saadat, Seyed H.
    Szalontay, Luca
    Block, Norman L.
    Kazzazi, Amir
    Djavan, Bob
    Schally, Andrew V.
    CURRENT OPINION IN UROLOGY, 2013, 23 (01) : 17 - 24
  • [10] Role of Prostatic Inflammation in the Clinical Presentation of Benign Prostatic Hyperplasia
    Nickel, J. Curtis
    EUROPEAN UROLOGY SUPPLEMENTS, 2015, 14 (09) : E1459 - E1463
12345